Author

Julien Calvo

InsermORCID 0000-0003-1316-4306Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Organism:human· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Françoise PflumioiD· 3 shared Laurent RenouiD· 3 shared Arnaud PetitiD· 2 shared Benjamin UzaniD· 2 shared Paola Fabiola BalleriniiD· 2 shared Vilma Barroca· 2 shared Alessandra MagnaniiD· 1 shared Andreas ReinischiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Françoise PflumioORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologyHemaSpherePeer-reviewedApr 1, 2025

Humanized in vivo bone marrow models orchestrate multi-lineage human hematopoietic cell development

Laurent Renou, Wenjie Sun, Chloé Friedrich…·Françoise Pflumio

This study characterizes a humanized in vivo bone marrow model, hOss, showing its impact on human hematopoietic development and clonal interactions.

5 citations

𝕏 PostBluesky

Cancer BiologyLeukemiaPeer-reviewedNov 23, 2024

High CD44 expression identifies rare chemoresistant leukemic cells endowed with enhanced E-Selectin binding in T-ALL

Julien Calvo, Irina Naguibneva, Anthony Kypraios…·Françoise Pflumio

The paper identifies a chemoresistant leukemic stem cell population in T-ALL with high CD44 expression and enhanced E-selectin binding, associated with poor prognosis and relapse.

10 citations

𝕏 PostBluesky

Cancer BiologyBiomedicine & PharmacotherapyPeer-reviewedJul 1, 2024

T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor

Charly Le Maout, Lucine Fahy, Laurent Renou…·Vanessa Petit

This study identifies an inflammatory microenvironment in T-ALL that supports progression, with HGF as a potential therapeutic target.

3 citations

mouseexperimental assay

𝕏 PostBluesky